Discover 522 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 522
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Memphis TN, St Louis MO, Atlanta GA, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase2, Phase3, Recruiting
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
for
Post-ligation Cardiac Syndrome
Location: Memphis TN, Atlanta GA, Cincinnati OH, Oklahoma City OK,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT06679855
Phase3, Recruiting
Quantifying the Impact of the Peanut Ball on the Duration of the Active Stage of Labor
for
Labor Onset and Length Abnormalities, Prolonged Labor,
Location: Memphis TN
Sponsor: University of Tennessee
Sex: Female
Age: 16+
Code: NCT05489315
Recruiting
The Management of Diabetes in Everyday Life Program
for
Diabetes Mellitus, Chronic Disease
Location: Memphis TN, Bartlett TN, Jackson TN
Sponsor: University of Tennessee
Sex: All
Age: 18+
Code: NCT02957513
Recruiting
Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
for
Extra Uterine Growth Restriction, Premature Infant Disease,
Location: Memphis TN
Sponsor: University of Tennessee
Sex: All
Age: 0
Code: NCT06731439
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Low-Dose Ketamine Infusion During Burn Wound Care
for
Burn, Pain, Dissociation, Opioid
Location: Memphis TN
Sponsor: University of Tennessee
Sex: All
Age: 18+
Code: NCT06506565
Recruiting
Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)